FDA's Anti-Infective Drugs Advisory Committee
Executive Summary
Will meet Nov. 28-29 to discuss the use of fluorophotometry as an endpoint for ocular inflammation, and blepharitis as an indication for ocular quinolones. Discussion on the second day will focus on use of trimethoprim/sulfamethoxazole in treating traveler's diarrhea. Two NDAs will be considered in closed session. Meeting will be held in Parklawn Building, Conference Room D, beginning at 8 a.m. both days. . . .
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.